Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OABSS Response to Solifenacin in Chinese Patients with Overactive Bladder
ChiCTR-TNC-10000948Phase 4Completed
- Sponsor
- Beijing Hospital
- Start
- Mar 2010
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of solifenacin in overactive bladder (OAB), sponsored by Beijing Hospital. Primary endpoint: Overactive Bladder Symptom Score (OABSS). Started Mar 2010; status: completed.
02
Drugs
solifenacin
03
Conditions
overactive bladder (OAB)
Beyond the preview
Go deeper on ChiCTR-TNC-10000948.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TNC-10000948.